S. Buscemi, V. Frenna, A. Pace, N. Vivona, B. Cosimelli, D. Spinelli
Table 4. Physical data for the acylamino-1,2,4-oxadiazoles 10mϪr and 11mϪr
FULL PAPER
Compd. M.p. [°C][a][b] IR [cmϪ1
]
1H NMR, δ ([D6]DMSO)
HRMS
Elemental analyses
10m
10n
10o
10p
116Ϫ118 (A) 3250, 3200, 3100, 1665 2.60 (s, 3 H), 3.95 (s, 3 H), 7.10Ϫ7.72 (m, 4 H), found 233.08029
10.94 (s, 1 H) calcd. 233.08004
156Ϫ158 (A) 3240, 3210, 3080, 1690 2.39 (s, 3 H), 2.57 (s, 3 H), 7.27Ϫ8.02 (m, 4 H), found 217.08531
found C 56.72, H 4.65, N 17.98
calcd. C 56.65, H 4.74, N 18.02
found C 60.58, H 5.12, N 19.20
calcd. C 60.82, H 5.10, N 19.34
found C 50.39, H 3.26, N 17.55
calcd. C 50.54, H 3.39, N 17.68
found C 42.39, H 2.71, N 14.81
calcd. C 42.58, H 2.86, N 14.90
11.41 (s, 1 H)
calcd. 217.08513
152Ϫ153 (A) 3240, 3190, 3100, 1665 2.62 (s, 3 H), 7.47-8.13 (m, 4 H), 11.69 (s, 1 H)
160Ϫ162 (A) 3230, 3190, 3100, 1700 2.62 (s, 3 H), 7.45Ϫ8.06 (m, 4 H), 11.70 (s, 1 H)
10q
10r
138 (A)[c]
145 (A)[c]
11m
124 (B)
3240, 3150, 1690
2.17 (s, 3 H), 3.97 (s, 3 H), 7.15Ϫ8.00 (m, 4 H), found 233.08039
11.30 (s, 1 H) calcd. 233.08004
3230, 3200, 3100, 1690 2.19 (s, 3 H), 2.69 (s, 3 H), 7.46Ϫ8.06 (m, 4 H), found 217.08542
11.27 (s, 1 H) calcd. 217.08513
found C 56.81, H 4.67, N 17.88
calcd. C 56.65, H 4.74, N 18.02
found C 60.63, H 5.16, N 19.27
calcd. C 60.82, H 5.10, N 19.34
11n
11o
11p
165 (B)
130Ϫ132 (B) 3210, 3160, 3100, 1690 2.20 (s, 3 H), 7.26Ϫ8.14 (m, 4 H), 11.38 (s, 1 H) found 237.03091[d] found C 50.42, H 3.20, N 17.52
calcd. 237.03050 calcd. C 50.54, H 3.39, N 17.68
143Ϫ145 (B) 3230, 3180, 3100, 1670 2.20 (s, 3 H), 7.45Ϫ8.06 (m, 4 H), 11.38 (s, 1 H) found 280.98032[e] found C 42.64, H 2.69, N 14.76
calcd. 280.97999
calcd. C 42.58, H 2.86, N 14.90
11q
11r
124 (A)[c]
163 (C)[c]
[a]
[b]
Melting points can be affected by a thermally induced rearrangement. All new compounds are colourless. Crystallisation solvents:
A: benzene; B: ethanol; C: ethyl acetate. [c] Ref.[21]: 10q: m.p. 138 °C; 10r: m.p. 145 °C; 11q: m.p. 124 °C; 11r: m.p. 163 °C. [d] 35Cl isotope.
[e] 79Br isotope.
In CD3OD in the Presence of tBuOK: Samples of 3-aroylamino-
Experimental Section
5-methyl-1,2,4-oxadiazoles 10 (1.8·10Ϫ2 mmol) in CD3OD (1 mL)
containing tBuOK (3.6·10Ϫ2 mmol)[22] reached equilibrium after
General Remarks: Melting points were determined with a Kofler
hot-stage apparatus and are uncorrected. IR spectra (Nujol) were
standing for 30 min and were then analysed by NMR. Representat-
ively, the equilibration reaction was also carried out starting from
determined with a PerkinϪElmer 257 instrument, 1H NMR spectra
3-acetylamino-5-aryl-1,2,4-oxadiazoles (i.e., 11mϪn), the same
were recorded with a Bruker 250 E spectrometer (tetramethylsilane
equilibrium compositions being observed.
as internal standard). Analytical determinations were carried out
by 1H NMR, integrating the methyl singlets in the ranges δ ϭ
Acknowledgments
2.39Ϫ2.62 (characteristic of 5-methyl of 10) and 2.17Ϫ2.20 (char-
acteristic of the 3-acetylamino group of 11), respectively. Composi-
We thank the CNR, the MURST and the University of Bologna
tions at equilibrium (expressed in % of the two isomers) represent
for financial support.
average values (with an uncertainty lower than Ϯ2%) of at least
three independent determinations. Compounds 10 were prepared
by treatment of 3-amino-5-methyl-1,2,4-oxadiazole[20,21] with the
appropriate aroyl chloride by the procedure previously descri-
bed.[3a,3d,7] Compounds 11 were prepared by isoheterocyclic re-
arrangement of the corresponding 10 by refluxing for several hours
in ethanol. After removal of the solvent, the mixtures of 10 and 11
were separated by chromatography. Compounds 11q and 11r were
prepared by acetylation of 3-amino-5-aryl-1,2,4-oxadiazoles with
acetyl chloride in pyridine.[21] All new compounds gave satisfactory
analytical data (C, H, N). Significant physical data are collected
in Table 4.
A. J. Boulton, A. R. Katritzky, A. Majid-Hamid, J. Chem.
[1] [1a]
[1b]
Soc. C 1967, 2005Ϫ2007.
A. S. Afridi, A. R. Katritzky, C.
A. Ramsden, J. Chem. Soc., Perkin Trans. 1 1976, 315Ϫ320.
[1c]
A. J. Boulton, Lectures in Heterocyclic Chemistry, Hetero
Corporation, Provo, 1973. [1d]M. Ruccia, N. Vivona, D.
Spinelli, Adv. Heterocycl. Chem. 1981, 29, 141Ϫ169.
vona, S. Buscemi, V. Frenna, G. Cusmano, Adv. Heterocycl.
[1e]
N. Vi-
[1f]
Chem. 1993, 56, 49Ϫ154.
B. Cosimelli, S. Guernelli, D.
Spinelli, S. Buscemi, V. Frenna, G. Macaluso, J. Org. Chem.
2001, 66, 6124Ϫ6129.
[2] [2a]
´
D. Korbonits, I. Kanzel-Szvoboda, K. Horvath, J. Chem.
[2b]
´
K. Horvath, D. Kor-
Soc., Perkin Trans. 1 1982, 759Ϫ766.
Equilibration between 3-Aroylamino-5-methyl-1,2,4-oxadiazoles 10
and 3-Acetylamino-5-aryl-1,2,4-oxadiazoles 11
´
`
bonits, G. Naray-Szabo, K. Simon, J. Mol. Struct. (Theochem)
1986, 136, 215Ϫ227.
[3] [3a]
N. Vivona, G. Cusmano, M. Ruccia, D. Spinelli, J. Hetero-
In CD3OD: Samples of 3-aroylamino-5-methyl-1,2,4-oxadiazoles
10 (1.8·10Ϫ2 mmol) in CD3OD (1 mL) were maintained in NMR
tubes at 313.15 K until constant mixture composition. Equilibrium
was reached in 3Ϫ5 weeks, except for the 10m/11m couple, which
required 8 weeks. Representatively, the equilibration reaction was
also carried out starting from 3-acetylamino-5-aryl-1,2,4-oxadia-
zoles (i.e., 11mϪn), with the same equilibrium compositions being
observed.
[3b]
cycl. Chem. 1975, 12, 985Ϫ988.
N. Vivona, M. Ruccia, G.
Cusmano, M. L. Marino, D. Spinelli, J. Heterocycl. Chem.
1975, 12, 1327Ϫ1328. [3c] G. La Manna, S. Buscemi, V. Frenna,
[3d]
N. Vivona, D. Spinelli, Heterocycles 1991, 32, 1547Ϫ1557.
S. Buscemi, V. Frenna, N. Vivona, G. Petrillo, D. Spinelli, Tet-
rahedron 1995, 51, 5133Ϫ5142.
N. Vivona, J. Mol. Struct. (Theochem) 1998, 452, 67Ϫ74.
H. C. van der Plas, Adv. Heterocycl. Chem. 1999, 74, 153Ϫ240.
[3e]
G. La Manna, S. Buscemi,
[3f]
1422
Eur. J. Org. Chem. 2002, 1417Ϫ1423